Precise measurement of liver iron content (LIC) in patients with transfusional iron overload is important in iron-chelation therapy. MRI can be used as a non-invasive method to measure iron levels in the liver. Typically, R2 and R2* based methods are used for this purpose. In this work, we use human liver explants to demonstrate the degree to which steatosis and fibrosis are confounding factors for R2* and quantitative susceptibility mapping in LIC measurement.
This abstract and the presentation materials are available to members only; a login is required.